Menu
GWAS Study

Genome-wide survival study identifies PARL as a novel locus for clinical progression and neurodegeneration in Alzheimer's disease.

Chen SD, Zhang W, Feng YW et al.

36870520 PubMed ID
GWAS Study Type
212975 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CS
Chen SD
ZW
Zhang W
FY
Feng YW
WB
Wu BS
YL
Yang L
ZY
Zhang YR
WH
Wang HF
GY
Guo Y
DY
Deng YT
FJ
Feng JF
CW
Cheng W
DQ
Dong Q
YJ
Yu JT
Chapter II

Abstract

Summary of the research findings

Variability exists in the trajectories of Alzheimer's disease (AD). We aimed to identify genetic modulators of clinical progression in AD.

1,158 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

212975
Total Participants
GWAS
Study Type
Yes
Replicated
211,817 British ancestry individuals
Replication Participants
European
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.